Board of Directors
In the News
Media Coverage: NHIC to accelerate local healthtech innovations in SIngapore with up to S$1M grant
Read more about the media coverage on NHIC's new Clinical Innovation and Adoption Initiative to nurture promising healthtech projects for adoption and scaling across healthcare clusters in Singapore.
Media Release: Launch of a new initiative to accelerate the adoption of healthtech innovations across healthcare clusters in Singapore
The National Health Innovation Centre, Singapore (NHIC) has launched a Clinical Innovation and Adoption Initiative to nurture promising healthtech projects for adoption and scaling across healthcare clusters in Singapore. Projects selected can expect to receive funding of up to S$1 million each. The initiative is supported by theMinistry of Health and covers three clinical adoption themes: Screening, Diagnostics and Monitoring, and Intervention. The grant call for the first theme will open in November 2022.
ACTRIS: A new national enabler for cell and gene therapies in Singapore
In this article, Dr Sudipto Bari, Head, Strategic Development and Communications at the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) introduces the evolution of CGT in Singapore, as well as the potential impact and benefits the continued development of cell therapy will bring to Singapore and beyond.
Media Coverage: Project SG100K – DNA of 100,000 Singaporeans to be mapped to identify new ways to prevent diseases
Read more about the media coverage on PRECISE and Illumina's strategic partnership to sequence and analyse 100,000 Singaporean whole genomes (SG100K).
Media Release: Singapore launches Southeast Asia’s most comprehensive consented population study with 100,000 whole genomes for health and clinical breakthroughs
PRECISE, the central entity implementing Singapore’s National Precision Medicine (NPM) strategy, and Illumina, Inc (Illumina), a leader in genomics technology, announced a strategic partnership to sequence and analyse 100,000 Singaporean whole genomes (SG100K), to create for the first time, Southeast Asia’s most comprehensive consented population study.
Media Coverage: Clinical Trials Day 2022
In conjunction with Clinical Trials Day on 20 May 2022, The Straits Times and Channel NewsAsia featured articles which raised public awareness on clinical trials.
Media Coverage: Healthcare Research Gets a Boost from Launch of Consortium
Read more about the media coverage for the official launch of CRIS here.
Media Release: Launch of a New National Consortium to Advance Clinical Research and Innovation for Singapore
A new national consortium – the Consortium for Clinical Research and Innovation, Singapore (CRIS) – has been officially launched by the Minister for Health Mr Ong Ye Kung on 6 April 2022.
Media Coverage: Clinical Research Coordinator who journeys with cancer patients wins Distinguished Contributor Award
Lianhe Zaobao featured two recipients of the Distinguished Contributor Award for Clinical Research Coordinators (CRCs) on 18 December 2021. The article highlighted the important role that CRCs play as the bridge between patients and trial investigators.
Media Release: Nine Clinical Research Coordinators recognised with Distinguished Contributor Award
Presented by the Singapore Clinical Research Institute (SCRI), the Distinguished Contributor Award recognises exceptional clinical research coordinators for their commitment, dedication and significant contributions to the profession and clinical research community.
Media Coverage: CNA Talking Point – How Effective Is Sinovac? Inactivated Virus VS mRNA Vaccine
CRIS CEO Dr Danny Soon spoke with CNA Talking Point on what should one consider when deciding which vaccine to take and whether booster shots will be needed for those who are already vaccinated.
Media Coverage: Old is not always gold, and other drug safety myths
Dr Danny Soon, CEO of CRIS and Executive Director of SCRI, debunks vaccine and other drug safety myths by going back to the roots of what matters in drug development and safety assessments.
Media Coverage: COVID-19 vaccine could become like yearly flu shot, say experts on Straits Times’ panel discussion
Dr Danny Soon, CEO of CRIS and Executive Director of SCRI, warned that the pandemic is far from over, as a small leak can take hold among unvaccinated people - but people now can do something about it and get vaccinated.
Media Coverage: New, unregistered vaccines offer choices to those allergic to mRNA Covid-19 vaccines
Allowing access to vaccines that are already in use elsewhere will give people in Singapore more options, said Dr Danny Soon, CEO of CRIS and Executive Director of SCRI.
Media Coverage: Straits Times Panel on Living with COVID-19: Singapore’s New Normal
Watch Dr Danny Soon (CEO of CRIS and Executive Director of SCRI) and other expert panellists in a discussion on how testing, tracing and vaccinations will feature in Singapore's post-pandemic life.
Media Coverage: COVID-19 Vaccines Boosted
Dr Danny Soon, CEO of CRIS and Executive Director of SCRI, discuss how ongoing research and developments have informed and allowed for timely and rational adjustments to Singapore's vaccine deployment policies.
Media Release: Singapore launches next phase of National Precision Medicine Programme
Singapore launches next phase of National Precision Medicine Programme New national body established to further research insights, improve patient outcomes and create new economic opportunities for the biomedical technology industry Established to coordinate a whole of government effort, Precision Health Research, Singapore (PRECISE) seeks to improve patient outcomes, implement data-driven healthcare and capture economic value […]
Media Release: Singapore Deep-Tech Alliance debuts venture builder to drive sustainability through Singapore’s Industry 4.0 Transformation
Singapore Deep-Tech Alliance partners create sustainable ventures from advanced technologies
Media Release: New personalised healthcare partnership formed to improve outcomes for people with cancer in Singapore
New personalised healthcare partnership formed to improve outcomes for people with cancer in Singapore Singapore Translational Cancer Consortium, National Cancer Centre Singapore, National University Hospital and Roche signed a Memorandum of Understanding (MOU) to leverage data insights and deepen understanding of unique drivers of disease to help improve health outcomes Public sector partners will provide […]
Media Coverage: Extraordinary 2020 Vaccines Speed
CRIS CEO, Dr Danny Soon, articulates why the vaccine development effort for Covid-19 has been like no other.
Media Coverage: Precision medicine key to preventing disease
Precision Health Research, Singapore (PRECISE) was incorporated to coordinate a whole-of-government effort to implement Phase II of Singapore’s 10-year precision medicine strategy.
Media Coverage: Committee for Singapore’s Covid-19 vaccination strategy
The Ministry of Health (MOH) has appointed a 14-member Expert Committee on COVID-19 Vaccination to make recommendations to the government on Singapore’s COVID-19 vaccination strategy.
Media Coverage: Paediatric Acute Respiratory Distress Syndrome (PARDS)
SCRI was featured in today’s Lianhe Zaobao on Paediatric Acute Respiratory Distress Syndrome (PARDS).
[ANNOUNCEMENT] Appointment of CEO (CRIS) and ED (SCRI)
About the Consortium for Clinical Research and Innovation Singapore (CRIS) The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly owned subsidiary of MOH Holdings, has been established in 2020 with the goal of strengthening synergies and promulgating strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry […]